Cargando…
Flex-nucleoside analogues – Novel therapeutics against filoviruses
Fleximers, a novel type of flexible nucleoside that have garnered attention due to their unprecedented activity against human coronaviruses, have now exhibited highly promising levels of activity against filoviruses. The Flex-nucleoside was the most potent against recombinant Ebola virus in Huh7 cel...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Ltd.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5626011/ https://www.ncbi.nlm.nih.gov/pubmed/28465098 http://dx.doi.org/10.1016/j.bmcl.2017.04.069 |
_version_ | 1783268472134828032 |
---|---|
author | Yates, Mary K. Raje, Mithun R. Chatterjee, Payel Spiropoulou, Christina F. Bavari, Sina Flint, Mike Soloveva, Veronica Seley-Radtke, Katherine L. |
author_facet | Yates, Mary K. Raje, Mithun R. Chatterjee, Payel Spiropoulou, Christina F. Bavari, Sina Flint, Mike Soloveva, Veronica Seley-Radtke, Katherine L. |
author_sort | Yates, Mary K. |
collection | PubMed |
description | Fleximers, a novel type of flexible nucleoside that have garnered attention due to their unprecedented activity against human coronaviruses, have now exhibited highly promising levels of activity against filoviruses. The Flex-nucleoside was the most potent against recombinant Ebola virus in Huh7 cells with an EC(50) = 2 μM, while the McGuigan prodrug was most active against Sudan virus-infected HeLa cells with an EC(50) of 7 μM. |
format | Online Article Text |
id | pubmed-5626011 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | Elsevier Ltd. |
record_format | MEDLINE/PubMed |
spelling | pubmed-56260112018-06-15 Flex-nucleoside analogues – Novel therapeutics against filoviruses Yates, Mary K. Raje, Mithun R. Chatterjee, Payel Spiropoulou, Christina F. Bavari, Sina Flint, Mike Soloveva, Veronica Seley-Radtke, Katherine L. Bioorg Med Chem Lett Article Fleximers, a novel type of flexible nucleoside that have garnered attention due to their unprecedented activity against human coronaviruses, have now exhibited highly promising levels of activity against filoviruses. The Flex-nucleoside was the most potent against recombinant Ebola virus in Huh7 cells with an EC(50) = 2 μM, while the McGuigan prodrug was most active against Sudan virus-infected HeLa cells with an EC(50) of 7 μM. Elsevier Ltd. 2017-06-15 2017-04-22 /pmc/articles/PMC5626011/ /pubmed/28465098 http://dx.doi.org/10.1016/j.bmcl.2017.04.069 Text en © 2017 Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Article Yates, Mary K. Raje, Mithun R. Chatterjee, Payel Spiropoulou, Christina F. Bavari, Sina Flint, Mike Soloveva, Veronica Seley-Radtke, Katherine L. Flex-nucleoside analogues – Novel therapeutics against filoviruses |
title | Flex-nucleoside analogues – Novel therapeutics against filoviruses |
title_full | Flex-nucleoside analogues – Novel therapeutics against filoviruses |
title_fullStr | Flex-nucleoside analogues – Novel therapeutics against filoviruses |
title_full_unstemmed | Flex-nucleoside analogues – Novel therapeutics against filoviruses |
title_short | Flex-nucleoside analogues – Novel therapeutics against filoviruses |
title_sort | flex-nucleoside analogues – novel therapeutics against filoviruses |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5626011/ https://www.ncbi.nlm.nih.gov/pubmed/28465098 http://dx.doi.org/10.1016/j.bmcl.2017.04.069 |
work_keys_str_mv | AT yatesmaryk flexnucleosideanaloguesnoveltherapeuticsagainstfiloviruses AT rajemithunr flexnucleosideanaloguesnoveltherapeuticsagainstfiloviruses AT chatterjeepayel flexnucleosideanaloguesnoveltherapeuticsagainstfiloviruses AT spiropoulouchristinaf flexnucleosideanaloguesnoveltherapeuticsagainstfiloviruses AT bavarisina flexnucleosideanaloguesnoveltherapeuticsagainstfiloviruses AT flintmike flexnucleosideanaloguesnoveltherapeuticsagainstfiloviruses AT solovevaveronica flexnucleosideanaloguesnoveltherapeuticsagainstfiloviruses AT seleyradtkekatherinel flexnucleosideanaloguesnoveltherapeuticsagainstfiloviruses |